Impact of Teriparatide on Complications and Patient-Reported Outcomes of Patients Undergoing Long Spinal Fusion According to Bone Density
Journal of Bone and Joint Surgery · 07.02.2024 · 106 (3) · 206-217
DOI: 10.2106/jbjs.23.00272 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bone and Joint Surgery, online erschienen am 16.11.2023. Verfasst von Sarthak Mohanty und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Och Spine Hospital, Columbia University Irving Medical Center, New York, NY. Hauptthemen laut MEDLINE: Spinal Fusion, Pseudarthrosis, Kyphosis, Osteoporosis. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Background
Surgery for adult spinal deformity (ASD) poses substantial risks, including the development of symptomatic pseudarthrosis, which is twice as prevalent among patients with osteoporosis compared with those with normal bone mineral density (BMD). Limited data exist on the impact of teriparatide, an osteoanabolic compound, in limiting the rates of reoperation and pseudarthrosis after treatment of spinal deformity in patients with osteoporosis.
Methods
Osteoporotic patients on teriparatide (OP-T group) were compared with patients with osteopenia (OPE group) and those with normal BMD. OP-T patients were matched with OPE patients and patients with normal BMD at a 1:2:2 ratio. All patients had a minimum 2-year follow-up and underwent posterior spinal fusion (PSF) involving >7 instrumented levels. The primary outcome was the 2-year reoperation rate. Secondary outcomes included pseudarthrosis with or without implant failure, proximal junctional kyphosis (PJK), and changes in patient-reported outcomes (PROs). Clinical outcomes were analyzed using conditional logistic regression. Changes in PROs were analyzed using a mixed-effects model.
Results
Five hundred and forty patients (52.6% normal BMD, 32.9% OPE, 14.4% OP-T) were included. In the unmatched cohort, 2-year reoperation rates (odds ratio [OR] = 0.45 [95% confidence interval (CI): 0.20 to 0.91]) and pseudarthrosis rates (OR = 0.25 [95% CI: 0.08 to 0.61]) were significantly lower in the OP-T group than the OPE group. Seventy-eight patients in the OP-T group were matched to 156 patients in the OPE group. Among these matched patients, at 2 years, 23.1% (36) in the OPE group versus 11.5% (9) in the OP-T group had a reoperation (OR = 0.45, p = 0.0188), 21.8% (34) versus 6.4% (5) had pseudarthrosis with or without implant failure (OR = 0.25, p = 0.0048), and 6.4% (10) versus 7.7% (6) had PJK (OR = 1.18, p = 0.7547), respectively. At 2 years postoperatively, PROs were better among OP-T patients than OPE patients. Subsequently, 78 patients in the OP-T group were matched to 156 patients in the normal BMD group. Among these matched patients, there was no significant difference in 2-year reoperation (OR = 0.85 [95% CI: 0.37 to 1.98]), pseudarthrosis (OR = 0.51 [95% CI: 0.181 to 1.44]), and PJK rates (OR = 0.77 [95% CI: 0.28 to 2.06).
Conclusions
Osteoporotic patients on teriparatide demonstrated lower reoperation and symptomatic pseudarthrosis rates 2 years postoperatively compared with osteopenic patients. Moreover, patient-reported and clinical outcomes for osteoporotic patients on teriparatide were not different from those for patients with normal BMD. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Och Spine Hospital, Columbia University Irving Medical Center, New York, NY.
ORCID-Profile: Sarthak Mohanty, Zeeshan M Sardar, Fthimnir M Hassan, Joseph M Lombardi, Lawrence G Lenke
Zitieren
APA
Mohanty, S., Sardar, Z. M., Hassan, F. M., Lombardi, J. M., Lehman, R. A., & Lenke, L. G. (2024). Impact of Teriparatide on Complications and Patient-Reported Outcomes of Patients Undergoing Long Spinal Fusion According to Bone Density. Journal of Bone and Joint Surgery, 106(3), 206-217. https://doi.org/10.2106/jbjs.23.00272
Vancouver
Mohanty S, Sardar ZM, Hassan FM, Lombardi JM, Lehman RA, Lenke LG. Impact of Teriparatide on Complications and Patient-Reported Outcomes of Patients Undergoing Long Spinal Fusion According to Bone Density. Journal of Bone and Joint Surgery. 2024;106(3):206-217. doi:10.2106/jbjs.23.00272
BibTeX
@article{Mohanty2024,
author = {Mohanty, Sarthak and Sardar, Zeeshan M and Hassan, Fthimnir M and Lombardi, Joseph M and Lehman, Ronald A and Lenke, Lawrence G},
title = {Impact of Teriparatide on Complications and Patient-Reported Outcomes of Patients Undergoing Long Spinal Fusion According to Bone Density},
journal = {Journal of Bone and Joint Surgery},
year = {2024},
volume = {106},
number = {3},
pages = {206--217},
doi = {10.2106/jbjs.23.00272}
}
EUVIMED